2021
DOI: 10.1016/j.xcrm.2021.100251
|View full text |Cite
|
Sign up to set email alerts
|

Embryonic stem cells go from bench to bedside for Parkinson’s disease

Abstract: Stem-cell-derived transplants may soon be a promising treatment option for Parkinson's disease. In preparation for clinical trial, Piao et al. 1 report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 9 publications
(9 reference statements)
0
0
0
Order By: Relevance